查看購物車
  • Simplified Chinese
  • English
  • Japanese
非類固醇抗發炎藥市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告涵蓋：藥物類別、給藥途徑、適應症、配銷通路和地理
市場調查報告書
商品編碼
1858569

非類固醇抗發炎藥市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告涵蓋：藥物類別、給藥途徑、適應症、配銷通路和地理

Non-steroidal Anti-Inflammatory Drugs Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Drug Class, Route Of Administration, Indication, Distribution Channel, and Geography
出版日期: | 出版商: The Insight Partners | 英文 273 Pages | 訂單完成後即時交付

價格

非類固醇抗發炎藥 (NSAID) 市場規模預計將從 2024 年的 248.2 億美元成長到 2031 年的 383.8 億美元；預計 2025 年至 2031 年期間，該市場將以 6.5% 的複合成長率年成長。

推動市場成長的主要因素包括慢性疼痛疾病和發炎性疾病（如關節炎和頭痛）的日益普遍，以及非鴉片類非類固醇抗發炎藥物（NSAIDs）的廣泛應用。此外，NSAIDs使用中的個人化和精準醫療方法也可能在預測期內促進非類固醇抗發炎藥市場的成長。然而，日益增多的監管和研發壁壘是阻礙市場發展的因素之一。

根據世界衛生組織的數據，2019年全球約有5.28億人患有骨關節炎，這一數字比1990年加倍還多。值得注意的是，73%的骨關節炎患者年齡超過55歲，其中女性佔60%。 2020年，全球有6.19億人患有腰痛，預計到2050年，數字可能上升至8.43億。

非類固醇抗發炎藥 (NSAIDs) 被廣泛用於治療骨關節炎、肌肉損傷、頭痛和神經病變等疾病引起的疼痛。隨著全球人口老化和慢性發炎性疾病的日益普遍，對有效疼痛管理方案的需求持續成長。 NSAIDs 是一種經證實有效的疼痛和發炎治療方法。為此，製藥公司不斷創新，研發新的 NSAID 製劑以滿足不同患者的需求。例如，2023 年 1 月，VaroJ Pharma 推出了其 1.3% 雙氯芬酸依泊胺外用系統，這是 IBSA Pharma 公司 Flector（雙氯芬酸依泊胺）的授權仿藥，專門用於治療肌肉拉傷、扭傷和挫傷引起的急性疼痛。

此外，癌症治療的最新進展提高了癌症患者的存活率，同時也導致化療引起的周邊神經病變（CIPN）等慢性疼痛疾病的發生率增加。根據2025年1月發表在《區域麻醉與疼痛醫學》雜誌上的一項薈萃分析，CIPN影響約41.2%的慢性疼痛患者，其中接受鉑類或紫杉烷類化療的患者發病率顯著更高——肺癌患者的發病率高達60.26%。神經損傷引起的神經性疼痛，以及肌肉骨骼和發炎性疾病，正在大幅擴大非類固醇抗發炎藥物（NSAIDs）及相關鎮痛藥的市場。

因此，對非類固醇抗發炎藥 (NSAID) 治療常見慢性疾病的需求不斷成長，推動了非類固醇抗發炎藥 (NSAID) 市場的成長。

本報告透過比較公司分析，基於產品組合（產品滿意度、產品特性和可用性）、近期市場發展（併購、新產品上市及改進、投資及融資、獎項、協議、合作與夥伴關係、認可和擴張）以及地域分佈，對非類固醇抗發炎藥 (NSAID) 市場預測進行評估和分類，從而幫助企業更好地進行決策並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭格局並更好地進行並了解競爭格局並了解競爭格局並了解競爭格局並了解競爭並更好地進行競爭格局並了解競爭格局。報告深入探討了全球非類固醇抗發炎藥物 (NSAID) 市場領先供應商近期取得的重大進展和創新。主要市場參與者包括：輝瑞 (B Pfizer)、拜耳 (Bayer AG)、格蘭馬克製藥有限公司 (Glenmark Pharmaceuticals Ltd.)、瑞迪博士實驗室有限公司 (Dr. Reddy's Laboratories Ltd)、勃林格殷格翰國際工業有限公司 (Novarce Island AG)、希克瑪製藥 (Hikma Pharmaceuticals) 和維亞特里斯公司 (Viatris Inc.)。

依藥物類別分類，市場可分為非選擇性非類固醇抗發炎藥（NSAIDs）和COX-2選擇性NSAIDs。 2024年，非選擇性NSAIDs佔據了最大的市場佔有率，預計在2025年至2031年期間將保持最高的複合年成長率（CAGR）。

依給藥途徑分類，非類固醇抗發炎藥（NSAID）市場可分為口服、注射和外用。 2024年，口服製劑佔了非類固醇抗發炎藥（NSAID）市場最大的佔有率，預計在2025年至2031年期間將維持較高的複合年成長率。

從適應症來看，非類固醇抗發炎藥（NSAID）市場可分為關節炎、偏頭痛、眼科疾病和其他疾病。 2024年，關節炎領域在非類固醇抗發炎藥物（NSAID）市場中佔據主導地位，預計在2025年至2031年期間將維持最高的複合年成長率。

根據配銷通路，非類固醇抗發炎藥 (NSAID) 市場可分為醫院藥房、零售藥房和線上管道。 2024 年，零售藥局佔據了 NSAID 市場最大的佔有率。醫院藥局在慢性病管理和確保患者獲得價格合理的藥物方面發揮著日益重要的作用。醫院藥局在為住院患者和出院手術患者提供處方 NSAID 方面發揮著至關重要的作用。在這些場所，專業的監管確保了安全有效的鎮痛，尤其是在使用更新、更強效的注射劑型時。推動這一成長的最新創新包括固定劑量偏頭痛治療藥物，例如美洛昔康聯合利扎曲坦，以及旨在降低成本和提高可及性的生物相似藥 NSAID 的推出。此外，個人化醫療的興起，即使用旨在最大限度減少副作用的靶向 NSAID，正在促進其在醫院環境中的廣泛應用，因為在醫院環境中，醫生的密切監測至關重要。這些因素導致對非類固醇抗發炎藥的需求增加，並透過醫院藥房在全球範圍內擴大其分銷。

在非類固醇抗發炎藥 (NSAID) 市場營運的公司採用了多種有機成長和無機成長策略。有機成長策略主要包括產品上市和產品核准。無機成長策略則包括收購、合作和夥伴關係。這些成長策略使市場參與者能夠拓展業務、增強地理覆蓋，並促進整體市場成長。此外，收購和夥伴關係等策略也有助於鞏固客戶基礎並擴展產品組合。

目錄

第1章：引言

第2章：執行概要

  • 分析師市場展望

第3章：研究方法

  • 二手研究
  • 初步研究
    • 假設的提出：
    • 宏觀經濟因素分析：
    • 發展基礎數字：
    • 數據三角測量：
    • 國家層面資料：
  • 假設和局限性

第4章：非類固醇抗發炎藥（NSAID）市場概況

  • PEST分析

第5章：非類固醇抗發炎藥（NSAID）市場－主要市場動態

  • 非類固醇抗發炎藥（NSAID）市場－主要市場動態
  • 市場促進因素
    • 慢性疼痛疾病和發炎性疾病的盛行率不斷上升
    • 非類固醇抗發炎藥作為非鴉片類鎮痛藥的偏好轉變
  • 市場限制
    • 監管和發展障礙
  • 市場機遇
    • 市場參與者的策略性舉措
  • 未來趨勢
    • 非類固醇抗發炎藥物使用中的個人化和精準醫療方法
  • 駕駛員和安全帶的影響：

第6章：非類固醇抗發炎藥（NSAID）市場－全球市場分析

  • 2021-2031年非類固醇抗發炎藥（NSAID）市場收入
  • 非類固醇抗發炎藥（NSAID）市場預測分析

第7章：非類固醇抗發炎藥（NSAID）市場分析－依藥物類別分類

  • 非選擇性非類固醇抗發炎藥
  • COX-2選擇性非類固醇抗發炎藥

第8章：非類固醇抗發炎藥（NSAID）市場分析－依給藥途徑分類

  • 口服
  • 注射劑
  • 主題

第9章：非類固醇抗發炎藥（NSAID）市場分析－依適應症分類

  • 關節炎
  • 偏頭痛
  • 眼科疾病
  • 其他

第10章：非類固醇抗發炎藥（NSAID）市場分析－依配銷通路分類

  • 醫院藥房
  • 零售藥局
  • 線上管道

第11章：非類固醇抗發炎藥（NSAID）市場－地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章：競爭格局

  • 關鍵參與者熱力圖分析
  • 公司市佔率分析，2024 年

第13章：行業概況

  • 擴張
  • 新產品開發
  • 其他商業策略

第14章：公司簡介

  • Pfizer Inc
  • Bayer AG
  • Dr. Reddy's Laboratories Ltd
  • Glenmark Pharmaceuticals Ltd
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG
  • Hikma Pharmaceuticals Plc
  • Boehringer Ingelheim International GmbH
  • Viatris Inc
  • Haleon Plc

第15章：附錄

Product Code: TIPRE00004421

The nonsteroidal anti-inflammatory drugs (NSAID) market size is projected to rise from US$ 24.82 billion in 2024 to US$ 38.38 billion by 2031; the market is expected to register a CAGR of 6.5% during 2025-2031.

Major factors propelling the market growth include the increasing prevalence of chronic pain disorders and inflammatory conditions such as arthritis and headaches, and the surging adoption of non-opioid NSAIDs. Further, the personalized and precision medicine approaches in NSAIDS use will likely boost the nonsteroidal anti-inflammatory drugs (NSAID) market growth during the forecast period. However, the increasing regulatory and development barriers is among the market deterrents.

According to the World Health Organization, approximately 528 million people globally were affected by osteoarthritis in 2019-a figure that has more than doubled since 1990. Notably, 73% of osteoarthritis sufferers are over the age of 55, and females account for 60% of this population. In 2020, 619 million individuals worldwide experienced lower back pain, with projections indicating this number could rise to 843 million by 2050.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely prescribed for managing pain associated with conditions such as osteoarthritis, muscle injuries, headaches, and neuropathies. As the global population ages and chronic inflammatory diseases become more prevalent, the demand for effective pain management solutions continues to grow. NSAIDs offer a proven and efficient method for treating pain and inflammation. In response, pharmaceutical companies are innovating with new NSAID formulations to address diverse patient needs. For example, in January 2023, VaroJ Pharma launched its diclofenac epolamine topical system 1.3%, the authorized generic of IBSA Pharma's Flector (diclofenac epolamine), designed specifically for treating acute pain from strains, sprains, and contusions.

Moreover, recent advances in cancer therapies have led to a rise in cancer survivorship, accompanied by an increase in chronic pain conditions such as chemotherapy-induced peripheral neuropathy (CIPN). Based on a meta-analysis published in Regional Anesthesia and Pain Medicine in January 2025, CIPN affects around 41.2% of chronic pain patients, with notably higher rates among those undergoing platinum or taxane-based chemotherapy-60.26% prevalence in lung cancer patients. Neuropathic pain resulting from nerve damage, combined with musculoskeletal and inflammatory conditions, is substantially expanding the market for NSAIDs and related analgesics.

Therefore, the demand of NSAIDs for the treatment of prevalent chronic diseases is increasing the nonsteroidal anti-inflammatory drugs (NSAID) market growth.

The comparative company analysis evaluates and categorizes the nonsteroidal anti-inflammatory drugs (NSAID) market forecast based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global nonsteroidal anti-inflammatory drugs (NSAID) market. The key market players are B Pfizer, Bayer AG, Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd, Boehringer Ingelheim International GmbH, Haleon plc, Sun Pharmaceutical Industries Ltd, Novartis AG, Hikma Pharmaceuticals, Viatris Inc.

By drug class, the market is segmented into nonselective NSAIDS and cox-2 selective NSAIDs. The nonselective NSAIDS segment held the largest nonsteroidal anti-inflammatory drugs (NSAID) market share in 2024 and is expected to register the highest CAGR during 2025-2031.

By route of administration, the nonsteroidal anti-inflammatory drugs (NSAID) market is classified into oral, injectable and topical. The oral segment held the largest share of the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024 and is expected to register a higher CAGR during 2025-2031.

In terms of indication, the nonsteroidal anti-inflammatory drugs (NSAID) market is segmented into arthritis, migraine, ophthalmic diseases, and others. The arthritis segment dominated the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024 and is anticipated to register the highest CAGR during 2025-2031.

The market, based on distribution channel, is segmented into hospital pharmacies, retail pharmacies and online channels. The retail pharmacies segment held the largest share of the nonsteroidal anti-inflammatory drugs (NSAID) market in 2024. Hospital pharmacies are playing an increasingly prominent role in managing chronic diseases and ensuring access to affordable medications. Hospital pharmacies play a crucial role in providing prescription NSAIDs to inpatients and discharged surgical patients. Professional oversight in these settings ensures safe and effective pain relief, particularly with newer and more potent injectable formulations. Recent innovations driving this growth include fixed-dose migraine treatments, such as meloxicam combined with rizatriptan, as well as the introduction of biosimilar NSAIDs aimed at reducing costs and increasing accessibility. Moreover, the shift toward personalized medicine, which involves targeted NSAIDs designed to minimize side effects, is promoting greater adoption in hospital environments, where close physician monitoring is essential. These factors are contributing to increased demand for NSAIDs and expanding their distribution through hospital pharmacies globally.

Various organic and inorganic strategies are adopted by companies operating in the nonsteroidal anti-inflammatory drugs (NSAID) market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaborations, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Landscape

  • 4.1 PEST Analysis

5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Key Market Dynamics

  • 5.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Chronic Pain Disorders and Inflammatory Diseases
    • 5.2.2 Shifting Preference for NSAIDs as Non-Opioid Pain Management
  • 5.3 Market Restraints
    • 5.3.1 Regulatory and Development Barriers
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Personalized and Precision Medicine Approaches in NSAIDs Use
  • 5.6 Impact of Drivers and Restraints:

6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Global Market Analysis

  • 6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021-2031
  • 6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Market Forecast Analysis

7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Drug Class

  • 7.1 Non-Selective NSAIDs
    • 7.1.1 Overview
    • 7.1.2 Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 COX-2 Selective NSAIDs
    • 7.2.1 Overview
    • 7.2.2 COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Route of Administration

  • 8.1 Oral
    • 8.1.1 Overview
    • 8.1.2 Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Injectable
    • 8.2.1 Overview
    • 8.2.2 Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Topical
    • 8.3.1 Overview
    • 8.3.2 Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Indication

  • 9.1 Arthritis
    • 9.1.1 Overview
    • 9.1.2 Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Migraine
    • 9.2.1 Overview
    • 9.2.2 Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Ophthalmic Diseases
    • 9.3.1 Overview
    • 9.3.2 Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Analysis - by Distribution Channel

  • 10.1 Hospital Pharmacies
    • 10.1.1 Overview
    • 10.1.2 Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Retail Pharmacies
    • 10.2.1 Overview
    • 10.2.2 Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Online Channels
    • 10.3.1 Overview
    • 10.3.2 Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)

11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.2.2 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.2.3 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.2.3.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.2.4 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.2.4.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.2.5 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.2.5.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.2.6 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.2.6.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.2.7 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.1 North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.2.1 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.2.7.2.2 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.2.7.2.3 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.2.7.2.4 United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.2.7.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.3.1 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.2.7.3.2 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.2.7.3.3 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.2.7.3.4 Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.2.7.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.7.4.1 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.2.7.4.2 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.2.7.4.3 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.2.7.4.4 Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.3 Europe
    • 11.3.1 Europe Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.3.2 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.3.3 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.3.3.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.3.4 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.3.4.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.3.5 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.3.5.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.3.6 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.6.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.3.7 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.1 Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.2.1 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.2.2 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.2.3 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.2.4 United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.3.1 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.3.2 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.3.3 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.3.4 Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.4.1 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.4.2 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.4.3 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.4.4 France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.5 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.5.1 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.5.2 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.5.3 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.5.4 Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.6 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.6.1 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.6.2 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.6.3 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.6.4 Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.3.7.7 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.7.7.1 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.3.7.7.2 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.3.7.7.3 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.3.7.7.4 Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.4.2 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.4.3 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.4.3.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.4.4 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.4.4.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.4.5 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.4.5.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.4.6 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.6.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.4.7 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.1 Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.4.7.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.2.1 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.2.2 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.2.3 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.2.4 India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.3.1 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.3.2 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.3.3 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.3.4 China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.4.1 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.4.2 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.4.3 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.4.4 Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.5 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.5.1 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.5.2 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.5.3 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.5.4 Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.6 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.6.1 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.6.2 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.6.3 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.6.4 South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.4.7.7 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.7.7.1 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.4.7.7.2 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.4.7.7.3 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.4.7.7.4 Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Non-steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.5.2 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.5.3 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.5.3.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.5.4 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.5.4.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.5.5 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.5.5.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.5.6 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.6.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.5.7 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.1 Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.5.7.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.2.1 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.2.2 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.2.3 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.2.4 United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.7.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.3.1 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.3.2 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.3.3 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.3.4 Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.7.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.4.1 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.4.2 South Africa: Non-steroidal Anti-inflmatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.4.3 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.4.4 South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.5.7.5 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.7.5.1 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.5.7.5.2 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.5.7.5.3 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.5.7.5.4 Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
  • 11.6 South and Central America
    • 11.6.1 South and Central America Non-Steroidal Anti-inflammatory Drugs (NSAID) Market Overview
    • 11.6.2 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
    • 11.6.3 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
      • 11.6.3.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Drug Class
    • 11.6.4 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
      • 11.6.4.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Route of Administration
    • 11.6.5 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
      • 11.6.5.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Indication
    • 11.6.6 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.6.6.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Distribution Channel
    • 11.6.7 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.1 South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast Analysis - by Country
      • 11.6.7.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.2.1 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.6.7.2.2 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.6.7.2.3 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.6.7.2.4 Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.6.7.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.3.1 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.6.7.3.2 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.6.7.3.3 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.6.7.3.4 Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel
      • 11.6.7.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.6.7.4.1 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class
        • 11.6.7.4.2 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration
        • 11.6.7.4.3 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication
        • 11.6.7.4.4 Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Market Share Analysis, 2024

13. Industry Landscape

  • 13.1 Expansion
  • 13.2 New Product Development
  • 13.3 Other Business Strategies

14. Company Profiles

  • 14.1 Pfizer Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Bayer AG
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Dr. Reddy's Laboratories Ltd
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Glenmark Pharmaceuticals Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Sun Pharmaceutical Industries Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Novartis AG
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hikma Pharmaceuticals Plc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Boehringer Ingelheim International GmbH
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Viatris Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Haleon Plc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 Glossary of Terms
  • 15.2 About The Insight Partners

List Of Tables

  • Table 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation
  • Table 2. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 6. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 7. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 9. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 10. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 11. Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 12. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 13. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 14. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 15. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 16. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 17. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 18. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 19. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 20. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 21. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 22. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 23. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 24. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 25. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 26. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 27. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 28. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 29. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 30. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 31. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 32. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 33. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 34. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 35. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 36. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 37. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 38. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 39. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 40. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 41. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 42. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 43. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 44. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 45. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 46. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 47. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 48. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 49. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 50. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 51. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 52. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 53. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 54. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 55. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 56. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 57. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 58. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 59. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 60. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 61. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 62. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 63. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 64. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 65. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 66. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 67. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 68. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 69. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 70. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 71. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 72. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 73. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 74. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 75. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 76. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 77. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 78. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 79. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 80. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 81. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 82. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 83. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 84. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 85. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 86. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 87. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 88. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 89. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 90. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 91. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 92. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 93. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 94. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 95. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 96. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 97. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 98. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 99. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 100. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 101. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 102. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 103. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 104. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 105. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 106. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 107. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 108. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 109. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 110. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 111. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 112. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 113. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 114. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 115. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 116. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 117. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 118. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 119. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 120. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 121. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 122. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 123. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 124. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 125. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 126. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 127. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 128. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 129. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 130. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 131. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 132. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 133. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 134. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 135. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 136. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 137. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 138. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 139. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 140. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 141. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 142. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 143. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 144. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 145. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 146. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 147. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 148. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 149. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 150. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 151. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 152. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 153. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 154. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 155. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 156. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 157. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 158. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 159. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 160. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 161. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 162. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 163. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 164. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 165. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 166. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 167. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 168. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 169. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 170. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 171. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 172. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 173. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 174. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 175. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 176. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 177. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 178. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 179. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 180. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 181. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 182. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 183. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 184. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 185. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 186. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 187. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 188. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 189. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 190. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 191. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 192. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 193. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 194. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 195. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 196. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 197. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 198. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 199. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 200. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 201. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 202. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 203. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 204. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 205. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 206. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 207. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 208. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 209. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 210. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 211. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 212. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 213. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 214. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 215. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 216. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 217. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 218. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 219. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 220. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 221. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 222. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 223. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 224. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 225. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 226. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 227. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 228. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 229. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 230. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Drug Class
  • Table 231. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Drug Class
  • Table 232. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Route of Administration
  • Table 233. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Route of Administration
  • Table 234. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Indication
  • Table 235. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Indication
  • Table 236. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2024 (US$ Million) - by Distribution Channel
  • Table 237. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue Forecast, 2025-2031 (US$ Million) - by Distribution Channel
  • Table 238. Heat Map Analysis by Key Players
  • Table 239. Glossary of Terms, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

List Of Figures

  • Figure 1. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Revenue (US$ Million), 2021-2031
  • Figure 5. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Drug Class (2024 and 2031)
  • Figure 6. Non-Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. COX-2 Selective NSAIDs: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Route of Administration (2024 and 2031)
  • Figure 9. Oral: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Injectable: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Topical: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Indication (2024 and 2031)
  • Figure 13. Arthritis: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Migraine: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Ophthalmic Diseases: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Share (%) - by Distribution Channel (2024 and 2031)
  • Figure 18. Hospital Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Retail Pharmacies: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Online Channels: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 22. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 23. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 24. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 25. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 26. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 27. North America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 28. United States: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Canada: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Mexico: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 32. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 33. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 34. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 35. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 36. Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 37. United Kingdom: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. Germany: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. France: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. Italy: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Spain: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. Rest of Europe: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 44. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 45. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 46. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 47. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 48. Asia Pacific: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 49. India: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. China: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 51. Japan: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 52. Australia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. South Korea: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. Rest of APAC: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 56. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 57. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 58. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 59. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 60. Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 61. United Arab Emirates: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 62. Saudi Arabia: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 63. South Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 64. Rest of Middle East and Africa: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 65. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue, 2021-2031 (US$ Million)
  • Figure 66. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Drug Class (2024 and 2031)
  • Figure 67. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Route of Administration (2024 and 2031)
  • Figure 68. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Indication (2024 and 2031)
  • Figure 69. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Distribution Channel (2024 and 2031)
  • Figure 70. South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 71. Brazil: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 72. Argentina: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 73. Rest of South and Central America: Non-steroidal Anti-inflammatory Drugs (NSAID) Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 74. Company Market Share Analysis, 2024